Lifevantage Corp Stock Price, News & Analysis

LifeVantage (Nasdaq: LFVN) announced its planned expansion into Iceland, set to launch in September 2025. The company will introduce a select portfolio of its wellness products, including its flagship Protandim Nrf2 Synergizer, MindBody GLP-1 System, TrueScience Liquid Collagen, and LifeVantage ProBio.

The expansion includes three wellness product stacks: Healthy Glow Essentials Stack, Healthy Weight Stack, and Premium Stack. Alongside the product launch, LifeVantage will introduce its business opportunity through the Evolve Compensation Plan, allowing local entrepreneurs to join as Consultants.

LifeVantage (Nasdaq: LFVN) has announced expanded clinical trial results for its MindBody GLP-1 System™, showing enhanced effectiveness in natural GLP-1 production. The combined data from trials completed in April 2025 and fall 2024 demonstrated an average increase in GLP-1 of over 200%, up from the previously reported 140%.

The clinical studies revealed significant outcomes including average weight loss of 11 pounds within 12 weeks, with some participants losing up to 25 pounds. Key body composition improvements include up to 9% decrease in total body fat, 24% decrease in visceral fat, and 6% increase in skeletal muscle. Notably, 100% of weight lost was from fat, not muscle.

Participants reported substantial behavioral changes, with 95% experiencing decreased sugar cravings and over 85% reporting improved eating habits and reduced hunger. The company also completed an independent 12-week trial of the international formula (MB System) with similar positive results.

LifeVantage (Nasdaq: LFVN) hosted its global Activate 2025 virtual event, introducing the new "Summer in the Fast Lane" campaign and quarterly business initiative. The company unveiled a new High Speed Health Stack featuring MindBody GLP-1 System, Protandim Nrf2 Synergizer, PhysIQ Fat Burn, and a complimentary Protandim NAD Synergizer.

The campaign is part of a new quarterly business strategy designed to drive growth through focused sales sprints and includes incentives such as mini trips worldwide. The company also announced its upcoming U.S. Momentum Academy event scheduled for October 23-25 in Dallas, TX, which will offer in-person training and networking opportunities.

LifeVantage Corporation (LFVN), a health and wellness company, has announced a quarterly cash dividend of $0.045 per share of common stock. The dividend represents a 12.5% increase from the previous quarter. The dividend will be paid on June 13, 2025, to stockholders of record at the close of business on May 30, 2025. LifeVantage specializes in products designed to activate optimal health processes at the cellular level.

LifeVantage (LFVN) reported strong Q3 fiscal 2025 results with revenue reaching $58.4 million, up 21.1% year-over-year. Net income per diluted share doubled to $0.26 from $0.13 in the prior year. The Americas region showed robust growth of 29.5%, while Asia/Pacific & Europe saw a 7.2% decline. Gross profit margin improved by 210 basis points to 81.0%. The company's MindBody GLP-1 System™ drove strong demand, and international expansion continued with launches in multiple Asian and European markets. The company declared a dividend of $0.045 per share and maintained its fiscal 2025 guidance with expected revenue between $228-235 million and adjusted EBITDA of $21-24 million.

Key metrics include adjusted EBITDA of $6.4 million (vs $5.1M year ago), cash and equivalents of $22.5 million with no debt, and operating income of $4.1 million (vs $1.9M year ago).

LifeVantage (LFVN) concluded its annual Global Convention in Salt Lake City from April 24-26, 2025, attracting over 2,000 Independent Consultants worldwide. The event, centered on the 'Drive ERA' theme, featured key business updates and product announcements.

The company highlighted its MindBody GLP-1 System™ (MB System™), now expanding to Europe, Mexico, Thailand, Australia, and New Zealand. Recent clinical studies showed the product increased GLP-1 levels by over 200% on average.

Two new AXIO product flavors were unveiled: Peach Nectarine as a permanent decaf option launching April 29, and an event-exclusive Tiger's Blood flavor. The company also announced a Q2 Sales Incentive doubling bonuses for new Senior Consultant 1 ranks and revealed Thailand as the 2026 Executive Destination Trip location.

LifeVantage (Nasdaq:LFVN), a health and wellness company focused on cellular health products, has scheduled its third quarter fiscal year 2025 financial results announcement for May 6, 2025, after market close.

The company will host an investor conference call at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) on the same day. U.S. investors can participate by dialing (877) 704-4453, while international callers should use (201) 389-0920.

A replay will be available until May 20, 2025, accessible via (844) 512-2921 (U.S.) or (412) 317-6671 (international) using confirmation code 13752773. A live webcast will be simultaneously available on the company's Investor Relations website, with a 30-day archive period.

LifeVantage (LFVN) is expanding its MindBody GLP-1 System™ (MB System™) internationally following significant success in the U.S. market, where it contributed to a 49% year-over-year increase in fiscal Q2 revenue ending December 31, 2024.

The MB System™ launched on March 15, 2025, in Japan for both Consultants and Customers, while becoming available exclusively to Consultants in Australia, New Zealand, Europe, UK, Mexico, and Thailand, with customer access starting April 25. The product is designed to naturally activate the body's GLP-1 production for metabolic health benefits.

The expansion targets the growing global GLP-1 pharmaceutical market, valued at $53.46 billion in 2024 and projected to reach $156.71 billion by 2030 with a 17.5% CAGR. LifeVantage plans to launch the MB System™ in the Philippines and Taiwan in early summer, followed by Canada later in the year.

LifeVantage (LFVN) has announced the expansion of its LV360 initiative and Evolve Compensation Plan into the Philippines, Taiwan, Hong Kong, and Singapore markets, effective March 1, 2025. This marks Phase 3 of the global rollout, following successful launches in Canada, Mexico, and Europe in February 2024, and in the US, Australia, New Zealand, and Japan in March 2023.

The Evolve Compensation Plan is structured to provide multiple income streams for Consultants through business building and product sales initiatives. The plan features early income bonuses, performance rewards, and mentorship incentives, designed to support both product-focused entrepreneurs and team builders.

CEO Steve Fife emphasized that the LV360 transformation, initiated two years ago, has been important in adapting to current direct sales industry trends and empowering Consultants with essential tools for business growth.